Correlation Between NanoString Technologies and Syros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both NanoString Technologies and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NanoString Technologies and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NanoString Technologies and Syros Pharmaceuticals, you can compare the effects of market volatilities on NanoString Technologies and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NanoString Technologies with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NanoString Technologies and Syros Pharmaceuticals.

Diversification Opportunities for NanoString Technologies and Syros Pharmaceuticals

0.55

Correlation Coefficient

NanoString Technologies  Syros Pharmaceuticals

Very weak diversification

The 3 months correlation between NanoString and Syros is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding NanoString Technologies and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and NanoString Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NanoString Technologies are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of NanoString Technologies i.e., NanoString Technologies and Syros Pharmaceuticals go up and down completely randomly.

Pair Corralation between NanoString Technologies and Syros Pharmaceuticals

If you would invest  20.00  in Syros Pharmaceuticals on September 18, 2024 and sell it today you would earn a total of  1.00  from holding Syros Pharmaceuticals or generate 5.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	5.0%
Values	Daily Returns

NanoString Technologies  vs.  Syros Pharmaceuticals

NanoString Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NanoString Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, NanoString Technologies is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Syros Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Syros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with NanoString Technologies and Syros Pharmaceuticals

The main advantage of trading using opposite NanoString Technologies and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NanoString Technologies position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.

The idea behind NanoString Technologies and Syros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .